2,654
edits
Human Tissue Use and Transfer: Difference between revisions
Jump to navigation
Jump to search
m
Human Tissue Use and Transfer (view source)
Revision as of 11:25, February 18, 2020
, February 18, 2020no edit summary
mNo edit summary |
mNo edit summary |
||
| Line 19: | Line 19: | ||
</table> | </table> | ||
<br /> | <br /> | ||
[[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[International | [[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[Disclosing Foreign Support and International Activities]] | [[Health Care Vendor Interactions]] | [[Credit Hour Definition]] | [[Whistleblower]]<br /> | ||
<br /><br /> | <br /> | ||
Policy No.: '''8013'''<br /> | Policy No.: '''8013'''<br /> | ||
Effective Date: '''03/15/12'''<br /> | Effective Date: '''03/15/12'''<br /> | ||